EU Officials Recall Some Valsartan Medicines Due to Impurity EU Officials Recall Some Valsartan Medicines Due to Impurity

The European Medicines Agency is reviewing the medicines after an impurity, thought to be a probable human carcinogen, was detected in the active ingredient supplied by a Chinese company.News Alerts
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Cardiology News Alert Source Type: news